Get started
Author

Ståle Haugset Nymo

Observed names: Nymo, S.H., Nymo, Ståle, Nymo, Ståle H., Nymo, Ståle Haugset, S H Nymo, S Nymo, S. H. Nymo, S.H. Nymo, Stale Nymo, Ståle Nymo, Ståle H Nymo, Ståle H. Nymo, Ståle Nymo
Observed institutions: Oslo University Hospital, Scuola Superiore Sant'Anna, University of Oslo, Drammen Hospital, Vestre Viken Hospital Trust, Nordland Hospital Trust, British Heart Foundation, Nordland Hospital, Diakonhjemmet Hospital, UiT The Arctic University of Norway, University of Glasgow, University of Gothenburg
ORCID: 0009-0006-8100-8363
Observed ORCID: 0009-0006-8100-8363
OpenAlex ID: A5042358240
Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis
2018 · Alberto Aimo, James L. Januzzi, et al. · Circulation · 239
sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T
2018 · Michele Emdin, Alberto Aimo, et al. · Journal of the American College of Cardiology · 217
PDF
Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
2012 · L. Gullestad, T. Ueland, et al. · European Heart Journal · 162
Soluble ST2 is Associated with Adverse Outcome in Patients with Heart Failure of Ischaemic Aetiology
2012 · Kaspar Broch, Thor Ueland, et al. · European Journal of Heart Failure · 138
Beta-Blockers after Myocardial Infarction in Patients without Heart Failure
2025 · John Munkhaugen, Anna Meta D. Kristensen, et al. · New England Journal of Medicine · 119
Inflammatory cytokines as biomarkers in heart failure
2014 · Thor Ueland, Lars Gullestad, et al. · Clinica Chimica Acta · 119
NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective
2015 · Ø. Sandanger, E. Gao, et al. · Biochemical and Biophysical Research Communications · 106
Pentraxin-3 in Chronic Heart Failure: The CORONA and GISSI-HF Trials
2012 · Roberto Latini, Lars Gullestad, et al. · European Journal of Heart Failure · 102
PDF
The predictive value of galectin-3 for mortality and cardiovascular events in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
2012 · Lars Gullestad, Thor Ueland, et al. · American Heart Journal · 97
Inflammatory Cytokines in Chronic Heart Failure: Interleukin-8 is Associated with Adverse Outcome. Results from CORONA
2013 · Ståle H. Nymo, Johannes Hulthe, et al. · European Journal of Heart Failure · 96
PDF
Electrolyte imbalances in an unselected population in an emergency department: A retrospective cohort study
2019 · Kiarash Tazmini, Ståle H. Nymo, et al. · PLoS ONE · 81
PDF
Prognostic Effect of High-Sensitive Troponin T Assessment in Elderly Patients With Chronic Heart Failure: Results From the CORONA Trial
2013 · Jørgen Gravning, Erik T. Askevold, et al. · Circulation Heart Failure · 74
PDF
Fatty Acid Binding Protein 4 Is Associated with Carotid Atherosclerosis and Outcome in Patients with Acute Ischemic Stroke
2011 · Sverre Holm, Thor Ueland, et al. · PLoS ONE · 73
PDF
The association between neutrophil gelatinase‐associated lipocalin and clinical outcome in chronic heart failure: results from CORONA*
2011 · S. H. Nymo, T. Ueland, et al. · Journal of Internal Medicine · 67
PDF
High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure
2018 · Alberto Aimo, James L. Januzzi, et al. · International Journal of Cardiology · 62
Soluble Glycoprotein 130 Predicts Fatal Outcomes in Chronic Heart Failure: Analysis From the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
2012 · Erik Tandberg Askevold, Ståle Nymo, et al. · Circulation Heart Failure · 50
The cardiokine secreted F rizzled‐related protein 3, a modulator of W nt signalling, in clinical and experimental heart failure
2013 · E. T. Askevold, P. Aukrust, et al. · Journal of Internal Medicine · 47
PDF
Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure
2017 · Ståle H. Nymo, Pål Aukrust, et al. · JACC Heart Failure · 44
PDF
Early increase of specialized pro-resolving lipid mediators in patients with ST-elevation myocardial infarction
2019 · Linn E. Fosshaug, Romain A. Colas, et al. · EBioMedicine · 42
PDF
Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome
2019 · Alberto Aimo, James L Januzzi, et al. · European Journal of Preventive Cardiology · 40
PDF
Inflammatory biomarkers are associated with aetiology and predict outcomes in community-acquired pneumonia: results of a 5-year follow-up cohort study
2019 · William W. Siljan, Jan C. Holter, et al. · ERJ Open Research · 35
PDF
Altered Levels of Fatty Acids and Inflammatory and Metabolic Mediators in Epicardial Adipose Tissue in Patients With Systolic Heart Failure
2015 · Linn E. Fosshaug, Christen P. Dahl, et al. · Journal of Cardiac Failure · 32
Cytokine responses, microbial aetiology and short‐term outcome in community‐acquired pneumonia
2017 · William W. Siljan, Jan C. Holter, et al. · European Journal of Clinical Investigation · 30
PDF
Patient characteristics in sepsis-related deaths: prevalence of advanced frailty, comorbidity, and age in a Norwegian hospital trust
2023 · Marianne Ask Torvik, Stig Haugset Nymo, et al. · Infection · 27
PDF
Secreted Frizzled Related Protein 3 in Chronic Heart Failure: Analysis from the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
2015 · Erik Tandberg Askevold, Lars Gullestad, et al. · PLoS ONE · 26
PDF
Works count: 60
Citation count: 2,309
H-index: 25
I10-index: 35
Year
Topic
Type